Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances

被引:628
作者
Narayan, Reema [1 ]
Nayak, Usha Y. [1 ]
Raichur, Ashok M. [2 ]
Garg, Sanjay [3 ]
机构
[1] Manipal Acad Higher Educ, Dept Pharmaceut, Manipal Coll Pharmaceut Sci, Manipal 576104, Karnataka, India
[2] Indian Inst Sci, Dept Mat Engn, Bengaluru 560012, India
[3] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia
关键词
mesoporous silica nanoparticles; MCM-41; protocells; SBA-15; Stober's synthesis; tetraethyl orthosilicate; DRUG-DELIVERY SYSTEM; OVERCOMING MULTIDRUG-RESISTANCE; RESPONSIVE CONTROLLED-RELEASE; POORLY SOLUBLE DRUGS; PROOF-OF-CONCEPT; PORE-SIZE; TARGETED DELIVERY; IN-VITRO; FACILE SYNTHESIS; PARTICLE-SIZE;
D O I
10.3390/pharmaceutics10030118
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent advancements in drug delivery technologies utilizing a variety of carriers have resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike in the current times. Need for materials with high thermal, chemical and mechanical properties have led to the development of mesoporous silica nanoparticles (MSNs). These ordered porous materials have garnered immense attention as drug carriers owing to their distinctive features over the others. They can be synthesized using a relatively simple process, thus making it cost effective. Moreover, by controlling the parameters during the synthesis; the morphology, pore size and volume and particle size can be transformed accordingly. Over the last few years, a rapid increase in research on MSNs as drug carriers for the treatment of various diseases has been observed indicating its potential benefits in drug delivery. Their widespread application for the loading of small molecules as well as macromolecules such as proteins, siRNA and so forth, has made it a versatile carrier. In the recent times, researchers have sorted to several modifications in the framework of MSNs to explore its potential in drug resistant chemotherapy, antimicrobial therapy. In this review, we have discussed the synthesis of these multitalented nanoparticles and the factors influencing the size and morphology of this wonder carrier. The second part of this review emphasizes on the applications and the advances made in the MSNs to broaden the spectrum of its use especially in the field of biomedicine. We have also touched upon the lacunae in the thorough understanding of its interaction with a biological system which poses a major hurdle in the passage of this carrier to the clinical level. In the final part of this review, we have discussed some of the major patents filed in the field of MSNs for therapeutic purpose.
引用
收藏
页数:49
相关论文
共 294 条
  • [1] Abd-Elbary A, 2014, Int J Pharm Pharm Sci, V6, P183
  • [2] Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery
    Ahmadi, Ebrahim
    Dehghannejad, Nematollah
    Hashemikia, Samaneh
    Ghasemnejad, Merajaddin
    Tabebordbar, Hashem
    [J]. DRUG DELIVERY, 2014, 21 (03) : 164 - 172
  • [3] Akinjokun AI., 2016, Microporous and mesoporous materials, P105
  • [4] In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices
    Alexa, Iuliana Florentina
    Ignat, Maria
    Popovici, Roxana Florentina
    Timpu, Daniel
    Popovici, Eveline
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 436 (1-2) : 111 - 119
  • [5] Liposomal antibiotics for the treatment of infectious diseases
    Alhariri, Moayad
    Azghani, Ali
    Omri, Abdelwahab
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (11) : 1515 - 1532
  • [6] [Anonymous], 1996, AIDS Treat News, P3
  • [7] [Anonymous], 2015, STC.UNM, Patent No. [US8,992,984B1, 8992984, 8992984B1]
  • [8] Morin Flavonoid Adsorbed on Mesoporous Silica, a Novel Antioxidant Nanomaterial
    Arriagada, Francisco
    Correa, Olosmira
    Gunther, German
    Nonell, Santi
    Mura, Francisco
    Olea-Azar, Claudio
    Morales, Javier
    [J]. PLOS ONE, 2016, 11 (11):
  • [9] Biocompatibility of Mesoporous Silica Nanoparticles
    Asefa, Tewodros
    Tao, Zhimin
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2012, 25 (11) : 2265 - 2284
  • [10] Ashley C.E., 2017, U.S. Patent, Patent No. [20170165375A1, 20170165375]